Form 4: ReposiTrak CEO Randall Fields Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


ReposiTrak's CEO, Randall Fields, executed sales of common stock on March 17 and 18, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Randall Fields, CEO of ReposiTrak, Inc., filed a Form 4 detailing changes in beneficial ownership.
  • On March 17, 2025, Fields sold 2,500 shares of common stock at a weighted average price of $19.5041 per share.
  • On March 18, 2025, he sold an additional 5,000 shares at a weighted average price of $19.1961 per share.
  • The sales were executed under a Rule 10b5-1 trading plan adopted by Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust.
  • Following these transactions, Fields directly owns 3,683,955 shares of common stock.
  • He also indirectly owns shares through various entities, including RK Fields Charitable 2022, LLC (267,000 shares), Riverview Financial Corp. (615,260 common shares and 531,432 Series B Preferred shares), his spouse (30,667 common shares and 12,322 Series B Preferred shares), and Fields Management, Inc. (333,643 shares).

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment, but rather a planned transaction.

Risks

  • The sale of shares by a key executive could be perceived negatively by the market, although it is occurring under a pre-arranged trading plan.

Industry Context

Insider trading activity is always closely watched by investors. The use of a 10b5-1 plan is intended to provide transparency and avoid concerns about trading on inside information. It is common for executives to use these plans to diversify their holdings or meet financial obligations.

Comparison to Industry Standards

  • It's common for executives at publicly traded companies to utilize 10b5-1 trading plans to sell shares, similar to executives at companies like Oracle (ORCL) or Microsoft (MSFT).
  • The volume of shares sold is relatively small compared to the total outstanding shares, which is typical for routine transactions under such plans.
  • The weighted average prices achieved are within a normal range for market fluctuations, aligning with standard execution practices.

Stakeholder Impact

  • The share sales could have a minor impact on shareholder sentiment, but the pre-arranged nature of the sales mitigates potential concerns.

Key Dates

DateDescription
03/17/2025Sale of 2,500 shares of common stock.
03/18/2025Sale of 5,000 shares of common stock.
03/18/2025Date of Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.